The Latest

Considering Specialty Pharmacy? Make Your Move
Considering Specialty Pharmacy? Make Your MoveThere is a lot for growth in specialty pharmacy but chains and independent pharmacies should make their move soon if they want to enter this market. The window of opportunity is closing.
How to Deal with an Angry CustomerRetail pharmacists get tips on how to deal with angry customers.
Beyond Beta-Blockers: Ivabradine for CHFReview of new drug Ivabradine (Corlanor) approved by the FDA for the management of heart failure.
BD Targets Opioid Control IV Safety Med Availability
FDA Approves Drug to Treat Duchenne Muscular Dystrophy, but Congress Has Problems
$96.5 Million Generic Payout Latest Trouble for MylanA $96.5 million settlement is the latest in a series of pricing and competition issues Mylan has faced in the past year.
How New Biosimilars Will Impact the MarketMore biosimilars are coming onto the market , including competitors for Remicade and Neulasta.
Safety Concerns Over Some Hepatitis C DrugsThe ISMP has issued a report that links several direct-acting antiviral agents for hepatitis C to serious adverse side effects. But drug makers take issue.
Getting Reimbursed for Services Rendered: It’s no Magic TrickPharmacists use their expertise to help patients -- as well as insurance companies. But we do it for free!
Faulty Drug Interaction Overrides: We Have to Do BetterWe need a system that cries wolf only when a wolf actually appears--not every time a chihuahua dances by.